M Krakauer Selected Research

DNA (Deoxyribonucleic Acid)

12/2009

Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Krakauer Research Topics

Disease

9	Multiple Sclerosis 02/2013 - 08/2006
1	Hyperglycemia 01/2012
1	Anemia 01/2012
1	Inflammation (Inflammations) 08/2006

Drug/Important Bio-Agent (IBA)

6	InterferonsIBA 11/2012 - 08/2006
3	Interferon-betaIBA 12/2009 - 08/2006
2	Glatiramer Acetate (Copaxone)FDA Link 02/2013 - 03/2012
2	Interleukin-10 (Interleukin 10)IBA 02/2011 - 06/2008
2	Biomarkers (Surrogate Marker)IBA 12/2009 - 12/2009
2	Chemokine ReceptorsIBA 12/2009 - 08/2006
1	CTLA-4 AntigenIBA 11/2012
1	AntibodiesIBA 03/2012
1	CreatinineIBA 01/2012
1	Interferon Type IIBA 02/2011
1	Biological ProductsIBA 05/2010
1	Chemokine CXCL13IBA 12/2009
1	DNA (Deoxyribonucleic Acid)IBA 12/2009
1	Neutralizing AntibodiesIBA 12/2009
1	CytokinesIBA 06/2008
1	Messenger RNA (mRNA)IBA 06/2008
1	Interleukin-23 (Interleukin 23)IBA 06/2008
1	EnzymesIBA 08/2006
1	ImmunosorbentsIBA 08/2006

Therapy/Procedure

3	Therapeutics 05/2010 - 08/2006